Unnamed: 0,title,date,stock,sentiment
563282.0,Globus Medical shares are trading higher. Not seeing any company-specific news to justify the price action.,2020-05-21 14:12:00-04:00,GMED,positive
563283.0,"Globus Medical Shares Spike Sharply Higher, Up 9% For Session; Not Seeing News To Justify Price Action",2020-05-21 13:06:00-04:00,GMED,positive
563284.0,"UBS Maintains Buy on Globus Medical, Lowers Price Target to $61",2020-05-08 14:06:00-04:00,GMED,negative
563285.0,"Credit Suisse Maintains Outperform on Globus Medical, Raises Price Target to $57",2020-05-08 10:30:00-04:00,GMED,positive
563286.0,"Morgan Stanley Maintains Equal-Weight on Globus Medical, Raises Price Target to $52",2020-05-08 08:29:00-04:00,GMED,neutral
563287.0,"Needham Maintains Buy on Globus Medical, Lowers Price Target to $60",2020-05-08 06:56:00-04:00,GMED,negative
563288.0,"SVB Leerink Maintains Outperform on Globus Medical, Lowers Price Target to $56",2020-05-08 06:29:00-04:00,GMED,negative
563289.0,"Globus Medical Q1 EPS $0.290 Misses $0.380 Estimate, Sales $190.577M Miss $194.500M Estimate",2020-05-07 17:27:00-04:00,GMED,negative
563290.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,GMED,negative
563291.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,GMED,neutral
563292.0,"Wells Fargo Maintains Overweight on Globus Medical, Lowers Price Target to $50",2020-04-06 09:30:00-04:00,GMED,negative
563293.0,"Morgan Stanley Maintains Equal-Weight on Globus Medical, Lowers Price Target to $48",2020-03-27 09:31:00-04:00,GMED,negative
563294.0,BTIG Buys Into Globus Medical's Longer-Term Vision,2020-03-18 15:28:00-04:00,GMED,positive
563295.0,"Benzinga's Top Upgrades, Downgrades For March 18, 2020",2020-03-18 09:53:00-04:00,GMED,positive
563296.0,"BTIG Upgrades Globus Medical to Buy, Announces $46 Price Target",2020-03-18 08:44:00-04:00,GMED,neutral
563297.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,GMED,negative
563298.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,GMED,negative
563299.0,Globus Medical Reports $200M Buyback,2020-03-11 17:40:00-04:00,GMED,neutral
563300.0,"Credit Suisse Maintains Outperform on Globus Medical, Lowers Price Target to $59",2020-03-06 10:36:00-05:00,GMED,positive
563301.0,"Globus Medical Q4 EPS $0.44 Misses $0.52 Estimate, Sales $211.7M Beat $210.44M Estimate",2020-02-20 16:32:00-05:00,GMED,negative
563302.0,"The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study",2020-02-20 07:06:00-05:00,GMED,negative
563303.0,"Earnings Scheduled For February 20, 2020",2020-02-20 04:17:00-05:00,GMED,neutral
563304.0,"The Week Ahead In Biotech: Baudax Bio, Merck, Esperion Await FDA Decisions",2020-02-16 15:03:00-05:00,GMED,positive
563305.0,"The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV Announces Positive Peanut Allergy Study Findings, Applied Genetic Soars On Trial Results",2020-01-09 08:39:00-05:00,GMED,positive
563306.0,"Globus Medical Sees Prelim. Q4. Sales $211M vs $209.93M Est., Prelim. FY19 Sales $784.7M vs $783.95M Est.; Sees FY20 Adj. EPS $1.82 vs $1.92 Est., Sales $850M vs $854.39M Est.",2020-01-08 16:32:00-05:00,GMED,neutral
563307.0,"Benzinga's Top Upgrades, Downgrades For January 8, 2020",2020-01-08 10:56:00-05:00,GMED,positive
563308.0,"SunTrust Robinson Humphrey Initiates Coverage On Globus Medical with Buy Rating, Announces $67 Price Target",2020-01-08 09:52:00-05:00,GMED,neutral
563309.0,"Benzinga's Top Upgrades, Downgrades For January 2, 2020",2020-01-02 10:42:00-05:00,GMED,positive
563310.0,Stocks That Hit 52-Week Highs On Friday,2019-12-20 11:59:00-05:00,GMED,neutral
563311.0,"The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering",2019-12-20 08:12:00-05:00,GMED,positive
563312.0,Stocks That Hit 52-Week Highs On Thursday,2019-12-19 10:29:00-05:00,GMED,neutral
563313.0,"The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic",2019-12-19 07:52:00-05:00,GMED,negative
563314.0,Stocks That Hit 52-Week Highs On Wednesday,2019-12-18 10:43:00-05:00,GMED,neutral
563315.0,"UBS Maintains Buy on Globus Medical, Raises Price Target to $67",2019-12-18 08:17:00-05:00,GMED,neutral
563316.0,"The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data",2019-12-18 07:23:00-05:00,GMED,positive
563317.0,Stocks That Hit 52-Week Highs On Tuesday,2019-12-17 11:19:00-05:00,GMED,neutral
563318.0,"Morgan Stanley Maintains Equal-Weight on Globus Medical, Raises Price Target to $60",2019-12-17 09:07:00-05:00,GMED,neutral
563319.0,"The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO",2019-12-17 07:56:00-05:00,GMED,positive
563320.0,Stocks That Hit 52-Week Highs On Monday,2019-12-16 10:16:00-05:00,GMED,neutral
563321.0,Stocks That Hit 52-Week Highs On Friday,2019-12-13 11:19:00-05:00,GMED,neutral
563322.0,"Benzinga's Top Upgrades, Downgrades For December 13, 2019",2019-12-13 09:29:00-05:00,GMED,positive
563323.0,"The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer",2019-12-13 08:10:00-05:00,GMED,positive
563324.0,Stocks That Hit 52-Week Highs On Thursday,2019-12-12 10:21:00-05:00,GMED,neutral
563325.0,"Benzinga's Top Upgrades, Downgrades For December 12, 2019",2019-12-12 09:59:00-05:00,GMED,positive
563326.0,Wells Fargo Upgrades Globus Medical to Overweight,2019-12-12 07:03:00-05:00,GMED,negative
563327.0,"The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares",2019-12-10 07:56:00-05:00,GMED,positive
563328.0,Stocks That Hit 52-Week Highs On Friday,2019-12-06 10:33:00-05:00,GMED,neutral
563329.0,"The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen",2019-11-27 07:26:00-05:00,GMED,negative
563330.0,Stocks That Hit 52-Week Highs On Tuesday,2019-11-26 11:03:00-05:00,GMED,neutral
563331.0,"The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug",2019-11-26 08:06:00-05:00,GMED,positive
563332.0,"The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data",2019-11-20 07:25:00-05:00,GMED,positive
563333.0,"Morgan Stanley Maintains Equal-Weight on Globus Medical, Raises Price Target to $57",2019-11-08 08:49:00-05:00,GMED,neutral
563334.0,"Canaccord Genuity Maintains Buy on Globus Medical, Raises Price Target to $60",2019-11-07 12:18:00-05:00,GMED,neutral
563335.0,"Piper Jaffray Maintains Overweight on Globus Medical, Raises Price Target to $65",2019-11-07 10:23:00-05:00,GMED,negative
563336.0,"Cantor Fitzgerald Maintains Overweight on Globus Medical, Raises Price Target to $64",2019-11-07 06:56:00-05:00,GMED,negative
563337.0,Globus Medical Sees FY19 Sales $775M-$783M vs $775.83M Est.,2019-11-06 17:03:00-05:00,GMED,neutral
563338.0,"Globus Medical Q3 Adj. EPS $0.43 Beats $0.42 Estimate, Sales $196.215M Beat $185.86M Estimate",2019-11-06 17:02:00-05:00,GMED,neutral
563339.0,"The Daily Biotech Pulse: Sesen Rallies On Positive FDA Meeting, Supernus Flunks Late-Stage ADHD Trial, GW Pharma Earnings",2019-11-06 08:21:00-05:00,GMED,positive
563340.0,"Wells Fargo Maintains Market Perform on Globus Medical, Raises Price Target to $53",2019-10-08 08:20:00-04:00,GMED,positive
563341.0,Globus Medical Launches AUTOBAHN Intramedullary Nailing Platform at 2019 OTA Annual Meeting,2019-09-24 08:33:00-04:00,GMED,neutral
563342.0,Globus Medical shares are trading higher after the company reported better-than-expected Q2 sales results.,2019-08-02 14:14:00-04:00,GMED,positive
563343.0,"Globus Medical Q2 EPS $0.38 Misses $0.41 Estimate, Sales $194.5M Beat $184.93M Estimate",2019-08-01 16:58:00-04:00,GMED,negative
563344.0,"The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings",2019-08-01 07:18:00-04:00,GMED,negative
563345.0,"The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate",2019-07-27 14:32:00-04:00,GMED,negative
563346.0,"Wells Fargo Downgrades Globus Medical, Inc. Class A Common Stock to Market Perform",2019-05-24 07:38:00-04:00,GMED,positive
563347.0,Globus Medical Highlights New Clinical Study Results Evaluating Versatility Of ExcelsiusGPS System,2019-05-23 16:29:00-04:00,GMED,neutral
563348.0,Globus Medical shares are trading lower after the company reported worse-than-expected Q1 EPS and sales.,2019-05-03 09:46:00-04:00,GMED,neutral
563349.0,"The Daily Biotech Pulse: Obseva Reports Positive Endometriosis Drug Trial, Assembly Biosciences Execs Depart, Coherus Settles With Amgen",2019-05-03 07:49:00-04:00,GMED,positive
563350.0,"Globus Medical Q1 Adj. EPS $0.36 Misses $0.41 Estimate, Sales $182.947M Miss $186.59M Estimate",2019-05-02 17:59:00-04:00,GMED,negative
563351.0,"The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data",2019-05-02 08:16:00-04:00,GMED,positive
563352.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,GMED,positive
563353.0,Shares of several medical device companies are trading lower with the healthcare sector. Healthcare has seen weakness recently due to concerns over the future of the Affordable Act under Trump and healthcare policy uncertainty ahead of the 2020 election.,2019-04-17 12:45:00-04:00,GMED,negative
563354.0,Globus Medical Launches FORTIFY Variable Angle Expandable Corpectomy Spacer System,2019-04-15 16:34:00-04:00,GMED,neutral
563355.0,"Benzinga's Top Upgrades, Downgrades For February 28, 2019",2019-02-28 09:14:00-05:00,GMED,positive
563356.0,UBS Upgrades Globus Medical to Buy,2019-02-28 07:00:00-05:00,GMED,neutral
563357.0,"Globus Medical Sees FY19 Adj. EPS $1.72 vs $1.72 Est., Sales $770M vs $766.1M Est.",2019-02-21 16:21:00-05:00,GMED,neutral
563358.0,"Globus Medical Q4 Adj. EPS $0.43 Beats $0.39 Estimate, Sales $195.94M Beat $190.7M Estimate",2019-02-21 16:19:00-05:00,GMED,neutral
563359.0,Globus Medical's SECUREC Cervical Artificial Disc Receives Anthem Insurance Coverage,2019-01-24 16:21:00-05:00,GMED,neutral
563360.0,56 Biggest Movers From Yesterday,2019-01-10 05:16:00-05:00,GMED,neutral
563361.0,45 Stocks Moving In Wednesday's Mid-Day Session,2019-01-09 12:31:00-05:00,GMED,neutral
563362.0,Mid-Morning Market Update: Markets Open Higher; Lennar Earnings Top Views,2019-01-09 10:19:00-05:00,GMED,positive
563363.0,Globus Medical shares are trading higher after the company late Tuesday issued strong guidance for FY18 and Q4; The company issued mixed FY19 guidance.,2019-01-09 09:49:00-05:00,GMED,positive
563364.0,22 Stocks Moving In Wednesday's Pre-Market Session,2019-01-09 08:02:00-05:00,GMED,neutral
563365.0,"The Daily Biotech Pulse: BioMarin Trims Outlook, MediciNova Enrolls First Patient In Brian Cancer Drug Study",2019-01-09 07:39:00-05:00,GMED,negative
563366.0,"10 Stocks To Watch For January 9, 2019",2019-01-09 04:48:00-05:00,GMED,neutral
563367.0,"Globus Medical Sees FY19 $1.72 vs $1.75 Est., Sales $770M vs $765.66M Est.",2019-01-08 16:17:00-05:00,GMED,neutral
563368.0,"Globus Medical Inc. Sees Q4 Sales $195.5M vs $188.18M Est., FY18 Sales $712.5M vs $705.17M Est.",2019-01-08 16:16:00-05:00,GMED,neutral
563369.0,66 Biggest Movers From Yesterday,2019-01-03 05:00:00-05:00,GMED,neutral
563370.0,"Stocks Which Set New 52-Week Low Today, Wed., Jan. 2, 2019",2019-01-02 13:08:00-05:00,GMED,negative
563371.0,45 Stocks Moving In Wednesday's Mid-Day Session,2019-01-02 12:21:00-05:00,GMED,neutral
563372.0,Mid-Day Market Update: Crude Oil Up Over 3%; Prana Biotechnology Shares Jump,2019-01-02 12:01:00-05:00,GMED,negative
563373.0,Globus Medical shares are trading lower after Morgan Stanley downgraded the stock from Overweight to Equal-Weight and lowered the price target from $64 to $49.,2019-01-02 10:50:00-05:00,GMED,negative
563374.0,"Morgan Stanley Downgrades Globus Medical to Equal-Weight, Lowers Price Target to $49",2019-01-02 07:23:00-05:00,GMED,negative
563375.0,"Credit Suisse Initiates Coverage On Globus Medical with Outperform Rating, Announces $53 Price Target",2018-12-18 07:28:00-05:00,GMED,positive
563376.0,"UBS Initiates Coverage On Globus Medical with Neutral Rating, Announces $55 Price Target",2018-11-28 08:01:00-05:00,GMED,neutral
563377.0,"Cantor Maintains Overweight On Globus Medical Amid Belief Investors Should Not Be Significantly Concerned About FDA Warning Letter As Letter Is 'related to only one product, and the company has already responded to the FDA's primary concern'",2018-11-14 11:34:00-05:00,GMED,negative
563378.0,Globus Medical Shares Appear Unaffected Wed. Following Tues. Evening 8-K Filing Showing Co. Received FDA Warning Related To Inspection Of Its Human Biologics Facilities In Texas,2018-11-14 11:33:00-05:00,GMED,negative
563379.0,"Globus Medical Sees FY18 Sales $705M, Adj. EPS $1.62",2018-11-08 17:13:00-05:00,GMED,neutral
563380.0,"Globus Medical, Inc. Q3 EPS $0.39 Beats $0.32 Estimate, Sales $169.236M Beat $167.54M Estimate",2018-11-08 17:13:00-05:00,GMED,neutral
563381.0,"Globus Medical Acquires Nemaris, Which Markets And Develops Surgimap Surgical Planning Software",2018-09-13 16:31:00-04:00,GMED,neutral
563382.0,"Global Medical Sees FY18 Adj. EPS $1.55 vs $1.52 Estimate, Sales $700M vs $696.2M Est.",2018-08-01 17:12:00-04:00,GMED,neutral
563383.0,"Globus Medical Q2 EPS $0.44 Beats $0.35 Estimate, Sales $173.384M Beat $168.03M Estimate",2018-08-01 17:11:00-04:00,GMED,neutral
563384.0,"Benzinga's Biotech Pulse: Pfizer's Xeljanz Gets EU Nod, NewLink Losses Narrow, Neuralstem Commences Stroke Drug Trial",2018-08-01 09:01:00-04:00,GMED,negative
563385.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs",2018-07-28 14:04:00-04:00,GMED,neutral
563386.0,"Benzinga's Daily Biotech Pulse: EDAP Device Gets FDA Nod, Ampliphi Presents Positive Data, Agile To Cut Jobs",2018-06-08 09:20:00-04:00,GMED,positive
563387.0,Cantor Fitzgerald Taps Spinal Stocks: 4 Top Picks,2018-06-03 18:06:00-04:00,GMED,positive
563388.0,Benzinga's Daily Biotech Pulse: Organovo Falls On Earnings; Celgene Gets New CFO,2018-06-01 08:16:00-04:00,GMED,neutral
563389.0,"Cantor Fitzgerald Initiates Coverage On Globus Medical with Overweight Rating, Announces $65 Price Target",2018-06-01 07:59:00-04:00,GMED,negative
563390.0,"Benzinga's Daily Biotech Pulse: Clinical Hold For Crispr, Gilead Study Meets Endpoint, Akers Gets Grace Time",2018-05-31 08:22:00-04:00,GMED,positive
563391.0,"Benzinga's Daily Biotech Pulse: Chinese Cheer For Gilead, Immutep Presents Positive Phase 1 Data, FDA Accepts Exelixis sNDA",2018-05-30 08:14:00-04:00,GMED,positive
563392.0,"Globus Medical Announces Clinical Results for Lateral Expandable Technology, Co. Says Data Shows Expandable Interbody Lateral Spacers More Resistant to Subsidence",2018-05-15 16:28:00-04:00,GMED,neutral
563393.0,"Globus Medical Raises FY18 ~$690M To $695M, EPS ~$1.50 To ~$1.52",2018-05-02 16:47:00-04:00,GMED,neutral
563394.0,"Globus Medical Q1 EPS $0.41 Beats $0.36 Estimate, Sales $174.4M Beat $167.95M Estimate",2018-05-02 16:46:00-04:00,GMED,neutral
563395.0,"BTIG Sees Limited Upside For Globus Medical, Downgrades To Neutral",2018-04-16 15:46:00-04:00,GMED,negative
563396.0,"Benzinga's Top Upgrades, Downgrades For April 16, 2018",2018-04-16 09:11:00-04:00,GMED,positive
563397.0,BTIG Research Downgrades Globus Medical to Neutral,2018-04-16 07:10:00-04:00,GMED,neutral
563398.0,Globus Medical Launches ELSA System,2018-04-05 16:15:00-04:00,GMED,neutral
563399.0,Needham Upgrades Globus Medical to Buy,2018-04-04 08:41:00-04:00,GMED,neutral
563400.0,"Globus Medical Sees FY18 Adj. EPS $1.50 vs $1.43 Est., Sales $690M vs $684.72M Est.",2018-02-21 17:06:00-05:00,GMED,neutral
563401.0,"Globus Medical Reports Q4 Adj. EPS $0.38 vs $0.35 Est., Sales $176M vs $166.53M Est.",2018-02-21 17:06:00-05:00,GMED,neutral
563402.0,Globus Medical Q4 Earnings Preview,2018-02-21 09:45:00-05:00,GMED,neutral
563403.0,"Globus Medical Reports Q4 Prelim Sales ~$175.5M vs $165.5M Est., Sees FY17 Sales ~$635.4M vs $625M Est.; FY18 Sales ~$690M vs $680M Est, EPS ~$1.50 vs $1.38 Est.",2018-01-09 08:32:00-05:00,GMED,neutral
563404.0,Globus Med Option Alert: Jan 19 $45 Calls at the Ask: 1000 @ $0.75 vs 23 OI; Earnings 2/26 After Close [est] Ref=$43.99,2018-01-05 15:02:00-05:00,GMED,positive
563405.0,"Morgan Stanley Upgrades Globus Medical, Expects 17% Upside",2018-01-02 11:32:00-05:00,GMED,neutral
563406.0,Morgan Stanley Upgrades Globus Medical to Overweight,2018-01-02 07:21:00-05:00,GMED,negative
563407.0,Galmed Pharmaceuticals Raised Gross Proceeds of $11.6M Under ATM Programs During December 2017,2018-01-02 07:00:00-05:00,GMED,negative
563408.0,Wells Fargo Upgrades Globus Medical to Outperform,2017-12-04 08:05:00-05:00,GMED,positive
563409.0,Bank of America Upgrades Globus Medical to Neutral,2017-11-10 08:29:00-05:00,GMED,neutral
563410.0,Globus Medical Reaffirms FY 2017 Sales and Adj. EPS Guidance,2017-11-08 17:30:00-05:00,GMED,neutral
563411.0,"Globus Medical Reports Q3 Adj. EPS $0.30 vs $0.30 Est., Sales $151.74M vs $150.39M Est.",2017-11-08 17:29:00-05:00,GMED,neutral
563412.0,"Benzinga's Top Upgrades, Downgrades For September 7, 2017",2017-09-07 09:25:00-04:00,GMED,positive
563413.0,"BTIG Research Initiates Coverage On Globus Medical with Buy Rating, Announces $37.00 Price Target",2017-09-07 07:51:00-04:00,GMED,neutral
563414.0,Globus Medical Names David M. Demski CEO,2017-08-29 16:15:00-04:00,GMED,neutral
563415.0,Globus Medical Reports FDA 510(k) Clearance For Excelsius GPS,2017-08-17 09:17:00-04:00,GMED,neutral
563416.0,"Globus Medical Reports Q2 EPS $0.32 vs. $0.30 Est., Sales $152.4M vs. $151.04M Est.",2017-08-02 17:05:00-04:00,GMED,neutral
563417.0,Canaccord Genuity Upgrades Globus Medical to Buy,2017-05-04 07:32:00-04:00,GMED,neutral
563418.0,"Globus Medical Sees ~$625M vs $624M Est., EPS ~$1.27 vs $1.28 Est.",2017-05-03 17:41:00-04:00,GMED,neutral
563419.0,"Globus Medical Reports Q1 Adj. EPS $0.32 vs $0.31 Est., Sales $155.8M vs $149.8M Est.",2017-05-03 17:40:00-04:00,GMED,neutral
563420.0,8 Biggest Price Target Changes For Monday,2017-04-24 09:49:00-04:00,GMED,neutral
563421.0,The Market In 5 Minutes,2017-04-24 09:20:00-04:00,GMED,neutral
563422.0,"Barclays Downgrades Globus Medical To Underweight, Raises Price Target To $28",2017-04-24 06:24:00-04:00,GMED,neutral
563423.0,Globus Medical Stands On The Brink Of Inflection; Leerink Upgrades,2017-04-12 14:47:00-04:00,GMED,neutral
563424.0,"Benzinga's Top Upgrades, Downgrades For April 12, 2017",2017-04-12 10:13:00-04:00,GMED,positive
563425.0,"Leerink Swann Upgrades Globus Medical to Outperform, Announces $40.00 Price Target",2017-04-12 08:17:00-04:00,GMED,neutral
563426.0,22 Stocks Moving In Thursday's Pre-Market Session,2017-03-16 08:36:00-04:00,GMED,neutral
563427.0,"Globus Medical Sees FY17 Sales Of $625M vs. $624M Est., EPS $1.27 vs. $1.27 Est.",2017-02-27 16:47:00-05:00,GMED,neutral
563428.0,"Globus Medical Reports Q4 Adj. EPS $0.31 vs. $0.33 Est., Sales $151.6M vs. $149.3M Est.",2017-02-27 16:46:00-05:00,GMED,neutral
563429.0,Globus Medical Sees FY16 Sales $564M vs $560.39M Est,2017-01-10 17:09:00-05:00,GMED,neutral
563430.0,"Globus Medical Sees FY17 EPS $1.27, Inline",2017-01-10 17:08:00-05:00,GMED,neutral
563431.0,Globus Medical Reports Prelim Q4 Sales $151.6M vs $148.96M Est,2017-01-10 17:08:00-05:00,GMED,neutral
563432.0,Globus Medical Sees FY17 Sales $625M vs $625M Est.,2017-01-10 17:08:00-05:00,GMED,neutral
563433.0,"Aegis Capital Initiates Coverage On Globus Medical at Buy, Announces $31.00 Target",2016-11-30 07:13:00-05:00,GMED,neutral
563434.0,20 Biggest Mid-Day Losers For Wednesday,2016-11-09 13:10:00-05:00,GMED,negative
563435.0,"William Blair Downgrades Globus Medical, Inc. Class A Common Stock to Market Perform",2016-11-09 09:15:00-05:00,GMED,neutral
563436.0,"Oppenheimer Downgrades Globus Medical, Inc. Class A Common Stock to Perform",2016-11-09 09:15:00-05:00,GMED,neutral
563437.0,Benzinga's Top Downgrades,2016-11-09 09:06:00-05:00,GMED,positive
563438.0,25 Stocks Moving In Wednesday's Pre-Market Session,2016-11-09 08:28:00-05:00,GMED,neutral
563439.0,"JMP Securities Downgrades Globus Medical, Inc. Class A Common Stock to Market Perform",2016-11-09 06:57:00-05:00,GMED,positive
563440.0,"Globus Medical Sees FY16 Rev. ~$560M vs. Est. $574M, EPS ~$1.13 vs. Est. $1.20; FY17 Rev. ~$625M vs. Est. $640M",2016-11-08 16:19:00-05:00,GMED,neutral
563441.0,"Globus Medical Reports Q3 EPS $0.29 vs. Est. $0.29, Rev. $135.7M vs. Est. $139.25M",2016-11-08 16:18:00-05:00,GMED,neutral
563442.0,Globus Medical Sells off to Low on Volume; Attributed to MS Downgrade,2016-07-27 14:51:00-04:00,GMED,negative
563443.0,15 Biggest Mid-Day Losers For Wednesday,2016-07-27 12:54:00-04:00,GMED,negative
563444.0,Wells Fargo Downgrades Globus Medical to Market Perform,2016-07-27 07:48:00-04:00,GMED,positive
563445.0,Leerink Swann Downgrades Globus Medical to Market Perform,2016-07-27 07:47:00-04:00,GMED,neutral
563446.0,Alphatec To Sell International Operations To Globus Medical For $80M,2016-07-26 16:37:00-04:00,GMED,neutral
563447.0,"Globus Medical Sees FY16 Rev. $575M vs. Est. $583M, EPS $1.20 vs. Est. $1.20; Sees FY17 Rev. $640M vs. Est. $637M",2016-07-26 16:36:00-04:00,GMED,neutral
563448.0,"Globus Medical Reports Q2 EPS $0.29 vs. Est. $0.29, Rev. $137.5M vs. Est. $141.7M",2016-07-26 16:35:00-04:00,GMED,neutral
563449.0,Acacia Research Announces Settlement License Agreement With Globus Medical,2016-06-10 06:07:00-04:00,GMED,positive
563450.0,"Barclays Bullish On NuVasive, Globus Medical, Dislikes LDR Holding",2016-05-27 09:36:00-04:00,GMED,negative
563451.0,Benzinga's Top Initiations,2016-05-27 09:29:00-04:00,GMED,positive
563452.0,The Market In 5 Minutes: Happy Memorial Day Weekend,2016-05-27 08:52:00-04:00,GMED,positive
563453.0,"Barclays Initiates Coverage on Globus Medical at Equal-weight, Announces $26.00 PT",2016-05-27 03:52:00-04:00,GMED,neutral
563454.0,"Globus Medical Downgraded By Goldman, Sees 11% Downside",2016-05-16 09:46:00-04:00,GMED,negative
563455.0,"Goldman Sachs Downgrades Globus Medical to Sell, Lowers PT to $21.00",2016-05-16 06:15:00-04:00,GMED,negative
563456.0,"Globus Medical Sees FY16 Rev. ~$583M vs. Est. $584M, EPS ~$1.20 vs. Est. $1.20",2016-05-03 16:17:00-04:00,GMED,neutral
563457.0,"Globus Medical Reports Q1 EPS $0.29 vs. Est. $0.28, REv. $139.3M vs. Est. $140.3M",2016-05-03 16:16:00-04:00,GMED,neutral
563458.0,SIRF: Golbus Medical's 'Inside Job',2016-03-22 13:16:00-04:00,GMED,neutral
563459.0,"Globus Medical Shares Selling Off, SIRF Negative Report Out",2016-03-22 11:53:00-04:00,GMED,negative
563460.0,"Globus Medical Reports Q4 EPS $0.39 Vs Est $0.30, Sales $142.587M Vs Est $141.20M",2016-02-24 16:32:00-05:00,GMED,neutral
563461.0,"Globus Medical Reports Litigation Settlement With DePuy Sythes Products On 4 Patent Infringement Lawsuits, Terms Not Disclosed",2016-01-19 17:08:00-05:00,GMED,negative
563462.0,Bank of America Downgrades Globus Medical to Underperform,2016-01-08 08:08:00-05:00,GMED,neutral
563463.0,Globus Medical Finds Support At $26 Area Again,2016-01-07 13:08:00-05:00,GMED,positive
563464.0,"Globus Medical's FY16 Sales Guidance Tempers Q4, FY15 Above-The-Street Outlook",2016-01-06 18:07:00-05:00,GMED,negative
563465.0,"UPDATE: Globus Medical Reports Prelim FY15 $544.7M vs. Prior Guidance Of $539M, Sees FY16 Rev. $583M vs. Est. $590.26M and EPS $1.20 vs. Est. $1.18",2016-01-06 16:16:00-05:00,GMED,neutral
563466.0,UPDATE: Globus Medical Sees Q4 Sales ~$142.6M vs $139M Est.,2016-01-06 16:16:00-05:00,GMED,neutral
563467.0,"Globus Medical Issues Q4, FY Outlook",2016-01-06 16:15:00-05:00,GMED,neutral
563468.0,UPDATE: Globus Medical Sees FY 2015 $1.07 vs Est $1.05 & Revs $539M Vs Est $528.90M,2015-11-03 16:29:00-05:00,GMED,neutral
563469.0,"Globus Medical Reports Q3 Adj EPS $0.28 Vs Est $0.25, Sales $137M Vs Est $127.46M",2015-11-03 16:29:00-05:00,GMED,neutral
563470.0,"Morgan Stanley Initiates Coverage on Globus Medical at Overweight, Announces $32.00 PT",2015-09-26 21:44:00-04:00,GMED,negative
563471.0,Globus Medical Announces Key Executive Changes,2015-09-08 16:20:00-04:00,GMED,neutral
563472.0,"Globus Medical Reports Inline Q2 Adj EPS $0.25, Sales $133.6M Vs Est $126.89M; Sees 2015 Adj EPS $1.04 Vs Est $1.04 & Revs $524M Vs Est $518.49M",2015-07-30 16:47:00-04:00,GMED,neutral
563473.0,"Globus Medical Unveils RISE-L, Expandable Lateral Interbody Fusion Device",2015-07-01 16:46:00-04:00,GMED,neutral
563474.0,Globus Medical Names Grant Thornton LLP as Independent Auditor,2015-06-09 16:30:00-04:00,GMED,positive
563475.0,Globus Medical Appoints Daniel Scavilla as Senior VP and CFO,2015-04-23 16:54:00-04:00,GMED,neutral
563476.0,Wells Fargo Initiates Coverage on Globus Medical at Outperform,2015-04-14 16:25:00-04:00,GMED,positive
563477.0,"Globus Medical Reports Q4 EPS 0.30 Vs Est $0.25, Sales $128.8M Vs Est $127.77M",2015-02-25 16:12:00-05:00,GMED,neutral
563478.0,Globus Medical To Acquire Branch Medical Group For $52.9M,2015-02-25 16:11:00-05:00,GMED,neutral
563479.0,Globus Medical Analyst Roundup Following Preliminary Q4 Results,2015-01-07 13:38:00-05:00,GMED,neutral
563480.0,UPDATE: Oppenheimer Raises PT On Globus Medical On Pre-Announced 4Q14 Revenue,2015-01-07 10:25:00-05:00,GMED,neutral
563481.0,"Piper Jaffray Initiates Coverage on Globus Medical at Overweight, Announces $28.00 PT",2015-01-07 09:30:00-05:00,GMED,negative
563482.0,Globus Medical Sees FY2015 EPS $1.01 vs $1.02 Est; Sees Sales $510.0M vs $514.40M Est,2015-01-06 16:08:00-05:00,GMED,neutral
563483.0,Globus Medical Reports Prelim. Q4 Sales $128.50M vs $122.0M Est,2015-01-06 16:08:00-05:00,GMED,neutral
563484.0,Zynerba Pharmaceuticals Appoints Richard A. Baron VP and CFO,2015-01-05 07:31:00-05:00,GMED,neutral
563485.0,"Bank of America Maintains Buy on Globus Medical, Inc., Raises PT to $26.00",2014-11-11 10:06:00-05:00,GMED,neutral
563486.0,Benzinga's Top Initiations,2014-11-11 09:05:00-05:00,GMED,positive
563487.0,Brean Capital Initiates Globus Medical At Buy,2014-11-11 08:56:00-05:00,GMED,neutral
563488.0,"Brean Capital Initiates Coverage on Globus Medical, Inc. at Buy, Announces $28.00 PT",2014-11-11 05:59:00-05:00,GMED,neutral
563489.0,"Brean Capital Initiates Coverage on Globus Medical, Inc. at Buy, Announces $28.00 PT",2014-11-10 16:35:00-05:00,GMED,neutral
563490.0,Globus Medical Announces Acquisition of Transplant Technologies of Texas ,2014-10-23 16:33:00-04:00,GMED,neutral
563491.0,Top 4 Small-Cap Stocks In The Medical Appliances & Equipment Industry With The Highest Profit Margin ,2014-09-18 04:48:00-04:00,GMED,positive
563492.0,"Gabelli Initiates Coverage on Globus Medical, Inc. at Buy",2014-08-19 06:40:00-04:00,GMED,neutral
563493.0,Morning Market Losers ,2014-08-06 10:00:00-04:00,GMED,negative
563494.0,"Globus Medical, Inc. Reports Q2 EPS of $0.23, Inline; Revenue of $113.60M vs $119.83M Est",2014-08-05 16:38:00-04:00,GMED,neutral
563495.0,"Globus Medical, Inc. Reports Q1 EPS of $0.24 vs $0.22 Est; Revenue of $114.20M vs $113.59M Est",2014-04-29 16:48:00-04:00,GMED,neutral
563496.0,"Wallachbeth Downgrades Globus Medical, Inc. to Hold",2014-02-27 07:58:00-05:00,GMED,neutral
563497.0,"Globus Medical, Inc. Reports Q4 EPS of $0.25 vs $0.21 Est; Revenue of $115.20M vs $113.29M Est",2014-02-26 17:16:00-05:00,GMED,neutral
563498.0,"Globus Medical, Inc. Sees Q4 Sales $115.20M vs $113.30M Est",2014-01-14 16:31:00-05:00,GMED,neutral
563499.0,Globus Medical Raises FY13 Sales Outlook,2014-01-14 16:31:00-05:00,GMED,neutral
563500.0,"Globus Medical, Inc. Sees FY2014 Sales $480.0M-486.0M vs $487.10M Est",2014-01-14 16:31:00-05:00,GMED,neutral
563501.0,"Globus Medical Acquires Excelsius Surgical, Financial Terms Not Disclosed",2014-01-08 18:44:00-05:00,GMED,neutral
563502.0,"From 8-K from Globus Medical Shows Co. Received FDA Warning Letter on Sept. 27th, Cited Audubon, PA Facility Inspection",2013-10-15 09:17:00-04:00,GMED,negative
563503.0,"UPDATE: Goldman Sachs Downgrades Globus Medical as Execution, Share Gains are Offset by Valuation",2013-10-14 11:29:00-04:00,GMED,positive
563504.0,"Goldman Sachs Downgrades Globus Medical, Inc. to Neutral, Lowers PT to $18.00",2013-10-14 07:15:00-04:00,GMED,negative
563505.0,UPDATE: Oppenheimer Raises PT on Globus Medical Following Close of Patent Infringement Case,2013-06-24 10:40:00-04:00,GMED,negative
563506.0,"Oppenheimer Maintains Outperform on Globus Medical, Inc., Raises PT to $19.00",2013-06-24 10:00:00-04:00,GMED,neutral
563507.0,UPDATE: Piper Jaffray Reiterates Overweight on Globus Medical on Synthes Award in Line With Expectations,2013-06-17 15:33:00-04:00,GMED,positive
563508.0,Canaccord Genuity Reiterates Buy Rating on Globus Medical Following Synthes Legal Verdict,2013-06-17 12:22:00-04:00,GMED,positive
563509.0,"Globus Says Jury Found Three Products Did Infringe on Synthese, Jury Awards $16M in Damages, Globus Seeking to Overturn Ruling",2013-06-17 07:22:00-04:00,GMED,neutral
563510.0,"Wallachbeth Capital Initiates Coverage on Globus Medical, Inc. at Buy, Announces $19.00 PT",2013-05-17 08:14:00-04:00,GMED,neutral
563511.0,"Sidoti & Co. Initiates Coverage on Globus Medical, Inc. at Buy, Announces $20.00 PT",2013-05-13 15:07:00-04:00,GMED,neutral
563512.0,Stock Market Fake-Out: Where Is the Retrenchment?,2013-05-08 12:47:00-04:00,GMED,neutral
563513.0,"Globus Medical, Inc. Reports Q1 EPS of $0.21 vs $0.20 Est; Revenue of $105.0M vs $103.18M Est",2013-05-02 16:35:00-04:00,GMED,neutral
563514.0,"Globus Medical, Inc. Reports Q4 EPS of $0.22 vs $0.19 Est; Revenue of $100.50M vs $99.90M Est",2013-02-27 16:27:00-05:00,GMED,neutral
563515.0,Globus Medical Spikes Higher,2013-02-08 12:23:00-05:00,GMED,neutral
563516.0,"Globus Medical, Inc. Sees Q4 Sales $100.50M vs $97.90M Est",2013-01-15 08:47:00-05:00,GMED,neutral
563517.0,Stocks Hitting 52-Week Lows,2012-12-24 10:23:00-05:00,GMED,negative
563518.0,"Canaccord Genuity Maintains Buy on Globus Medical, Inc., Raises PT to $22.00",2012-12-14 08:22:00-05:00,GMED,neutral
563519.0,Mid-Day Market Update: Markets Flat Following Obama Interview,2012-12-04 14:27:00-05:00,GMED,neutral
563520.0,"Moves in Smaller Health Care Stocks (GMED, SEM, UAM, VRTX)",2012-11-03 10:07:00-04:00,GMED,positive
563521.0,Mid-Afternoon Market Update: Markets Remain Down,2012-11-02 15:49:00-04:00,GMED,neutral
563522.0,Globus Medical Reports Q3 EPS $0.18 vs $0.19 Est; Revenues $94.8M vs $95.32M Est,2012-11-01 16:11:00-04:00,GMED,neutral
563523.0,"Goldman Sachs Maintains Globus Medical at Buy, Raises PT from $18 to $19",2012-10-04 07:00:00-04:00,GMED,neutral
563524.0,UPDATE: Piper Jaffray Raises PT to $21 on Globus Medical  ,2012-10-01 13:24:00-04:00,GMED,neutral
563525.0,"Piper Jaffray Maintains Globus Medical  at Overweight, Raises PT from $18 to $21",2012-10-01 11:58:00-04:00,GMED,negative
563526.0,"Oppenheimer Maintains Globus Medical at Outperform, Raises PT from $18 to $19",2012-09-28 15:12:00-04:00,GMED,neutral
563527.0,"Canaccord Initiates Coverage on Globus Medical at Buy, Announces PT of $20",2012-08-28 08:56:00-04:00,GMED,neutral
563528.0,Benzinga's Top Initiations,2012-08-28 07:25:00-04:00,GMED,positive
563529.0,UPDATE: Bank of America Initiates Globus Medical at Buy with $17 PT  ,2012-08-28 07:00:00-04:00,GMED,neutral
563530.0,"Oppenheimer Initiates Coverage on Globus Medical at Outperform, Announces PT of $18",2012-08-28 06:19:00-04:00,GMED,neutral
563531.0,"Bank of America Initiates Coverage on Globus Medical at Buy, Announces PO of $17",2012-08-28 05:52:00-04:00,GMED,negative
563532.0,William Blair Initiates Coverage on Globus Medical  at Outperform,2012-08-27 12:46:00-04:00,GMED,neutral
563533.0,Benzinga's Top Initiations,2012-08-27 08:03:00-04:00,GMED,positive
563534.0,Globus Medical Announces Pricing of Initial Public Offering; 8.33M Shares at $12/Share,2012-08-03 08:46:00-04:00,GMED,positive
